A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway

Biochemical Journal

Volumn 422, Issue 2, 2009, Pages 363-372

  Li, Chunsun ^a   Chen, Hongyan ^a   Ding, Fang ^a   Zhang, Yu ^a   Luo, Aiping ^a   Wang, Mingrong ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Apoptosis; Oesophageal squamous cell carcinoma (ESCC); p53; Promoter; S100 calcium binding protein A9 (S100A9); Transcription

Indexed keywords

APOPTOSIS; OESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC); P53; PROMOTER; S100 CALCIUM-BINDING PROTEIN A9 (S100A9);

BINDING ENERGY; BINDING SITES; CALCIUM; CALCIUM ALLOYS; CELL MEMBRANES; ELECTROSLAG PROCESS; TRANSCRIPTION;

CELL DEATH;

CALGRANULIN B; LUCIFERASE; MESSENGER RNA; PROTEIN P53;

APOPTOSIS; ARTICLE; BINDING SITE; CELL LINE; CELL STRAIN HCT116; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; WILD TYPE; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CALGRANULIN B; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; GENE TARGETING; HUMANS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70149117029     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090465     Document Type: Article

References (47)

1. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70
2. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
3. Zhang, W., Bailey-Wilson, J. E., Li, W., Wang. X., Zhang, C., Mao, X., Liu, Z., Zhou, C. and Wu, M. (2000) Segregation analysis of esophageaf cancer in a moderately high-incidence area of northern China. Am. J. Hum. Genet. 67, 110-119
4. Lin, D. C., Du, X. L. and Wang, M. R. (2009) Protein alterations in ESCC and clinical implications: a review. Dis. Esophagus 22, 9-20
5. Hollstein, M., Hergenhahn, M., Yang, Q., Bartsch, H., Wang, Z. Q. and Hainaut, P. (1999) New approaches to understanding p53 gene tumour mutation spectra. Mutat. Res. 431, 199-209
6. Gao, H., Wang, L. D., Zhou, Q., Hong, J. Y., Huang, T. Y. and Yang, C. S. (1994) p53 tumour suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res. 54, 4342-4346
7. Lu, J., Liu, Z., Xiong, M., Wang, Q., Wang. X., Yang, G., Zhao, L., Diu. Z., Zhou, C. and Wu, M. (2001) Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int. J. Cancer 91, 288-294
8. Zhi, H., Zhang, J., Hu, G., Lu, J., Wang, X., Zhou, C., Wu, M. and Liu, Z. (2003) The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int. J. Cancer 106, 327-333
9. Luo, A., Kong, J., Hu, G., Liew, C. C., Xiong, M., Wang, X., Ji, J., Wang, T., Zhi, H., Wu, M. and Liu, Z. (2004) Discovery of Ca2-1 -relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23, 1291-1299
10. Gebhardt, C., Nemeth, J., Angel, P. and Hess. J. (2006) S100A8 and S100A9 in inflammation and cancer. Biochem, Pharmacol, 72, 1622-1631
11. Heizmann, C. W., Fritz, G. and Schafer, B. W. (2002) S100 proteins: structure, functions and pathology. Front. Bioscl. 7, d1356-d1368
12. Donato, R. (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellularand extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668
13. Salama, I., Malone, P. S., Mihaimeed, F. and Jones, J. L. (2008) A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357-364
14. Ji, J., Zhao. L., Wang, X., Zhou, C., Ding, F, Su, L., Zhang, C., Mao, X., Wu, M. and Liu, Z. (2004) Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 130, 480-486
15. Hunter, M. J. and Chazin, W. J. (1998) High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 273, 12427-12435
16. Kerkhoff, C., Klempt, M. and Sorg, C. (1998) Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta 1448, 200-211
17. Seeliger, S., Vogl, T., Engels, I. H., Schroder, J. M., Sorg, C., Sunderkotter, C. and Roth, J. (2003) Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am. J. Pathol. 163, 947-956
18. Ghavami, S., Kerkhoff, C., Los, M., Hashemi, M., Sorg, C. and Karami-Tehrani, F. (2004) Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukocyte Biol. 76, 169-175
19. Yui, S., Nakatani, Y. and Mikami, M. (2003) Calprotectin (S100A8/ S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull. 26, 753-760
20. Ghavami, S.. Kerkhoff, C., Chazin, W. J., Kadkhoda, K., Xiao, W., Zuse, A., Hashemi, M., Eshraghi, M., Schulze-Osthoff, K., Klonisch, I and Los, M. (2008) S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta 1783, 297-311
21. Vogl, T., Ludwig, S., Goebeler, M., Strey, A., Thorey, I. S., Reichelt, R., Foell, D., Gerke, V., Manitz, M. P., Nacken, W. et al. (2004) MRP8 and MRP14 control microbibule reorganization during transendothelial migration of phagocytes. Blood 104, 4260-4268
22. Hermani, A., De Servi, B., Medunjanin, S., Tessier, P. A. and Mayer, D. (2006) S100A8 and S100A9 activate MAP kinase and NF-ΚB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 312, 184-197
23. Anceriz, N, Vandal, K. and Tessier, P. A. (2007) S100A9 mediates neutrophil adhesion to fibronectin through activation of β2 integrins. Biochem. Biophys. Res. Commun. 354, 84-89
24. Hiratsuka, S., Watanabe, A., Aburatani, H. and Maru, Y. (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375
25. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N. and Tobe, T. (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69, 277-284
26. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W. and Vogelstein, B. (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945-1952
27. Han, Y., Wei, F., Xu, X., Cai, Y., Chen, B., Wang, J., Xia, S., Hu, H., Huang, X., Wu, M. and Wang, M. (2002) Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19, 455-457
28. Li, Y. X., Lin, Z. B. and Tan, H. R. (2004) Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells. Acta Pharmacol. Sin. 25, 76-82
29. Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M. and Vousden, K. H. (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15, 827-838
30. Zhang, Y., Feng, Y. B., Shen, X. M., Chen, B. S., Du, X. L., Luo, M. L., Cai, Y., Han, Y. L., Xu, X., Zhan, Q. M. and Wang, M. R. (2008) Exogenous expression of Esophagin/SPRR3 attenuates the tumourigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis. Int. J. Cancer 122, 260-266
31. Zhang, L., Ding, F., Cao, W., Liu, Z., Liu, W., Yu, Z., Wu, Y., Li, W. and Li, Y. (2006) Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin. Cancer Res. 12, 1639-1646
32. Celis, J. E., Gromova, I., Gromov, P., Moreira, J. M., Cabezon, T., Friis, E. and Rank, F. (2006) Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. FEBS Lett. 580, 2935-2944
33. Yin, Y., Liu, Y. X., Jin, Y. J., Hall, E. J. and Barrett, J. C. (2003) PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 422, 527-531
34. Fujii, T., Kato, S., Yamana, H., Tanaka, Y., Fujita, H., Shirouzu, K. and Morimatsu, M. (2001) Expression of G1 cell cycle markers and the effect of adenovirus-mediated overexpression of p21Waf-1 in squamous cell carcinoma of the esophagus. Int. J. Oncol. 18, 157-163
35. Kong, J. P., Ding, F., Zhou, C. N., Wang, X. Q., Miao, X. P., Wu, M. and Liu, Z. H. (2004) Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World J. Gastroenterol. 10, 1093-1097
36. Wang, J., Cai, Y., Xu, H., Zhao, J., Xu, X., Han, Y. L., Xu, Z. X., Chen, B. S., Hu, H., Wu, M. and Wang, M. R. (2004) Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer. Cell Res. 14, 46-53
37. Roesch Ely, M., Nees, M., Karsai, S., Magele, I., Bogumil, R., Vorderwulbecke, S., Ruess, A., Dietz, A., Schnolzer, M. and Bosch, F. X. (2005) Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur. J. Cell Biol. 84, 431-444
38. Cross, S. S., Hamdy, F. C., Deloulme, J. C. and Rehman, I. (2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46, 256-269
39. Arai, K., Teratani, T., Kuruto-Niwa, R., Yamada, T. and Nozawa, R. (2004) S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. Eur. J. Cancer 40, 1179-1187
40. El-Rifai, W., Moskaluk, C. A., Abdrabbo, M. K., Harper, J., Yoshida, C., Riggins, G. J., Frierson, Jr, H. F. and Powell, S. M. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62, 6823-6826
41. Hermani, A., Hess, J., De Servi, B., Medunjanin, S., Grobholz, R., Trojan, L., Angel, P. and Myer, D. (2005) Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin. Cancer Res. 11, 146-5152
42. Ott, H. W., Lindner, H., Sarg, B., Mueller-Holzner, E., Abendstein, B., Bergant, A., Fessler, S., Schwaerzler, P., Zeimet, A., Marth, C. and Illmensee, K. (2003) Calgranulins in cystic fluid and serum from patients with ovarian carcinomas. Cancer Res. 63, 7507-7514
43. Vogelstein, B., Lane, D. and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
44. Lin, J., Yang, Q., Yan, Z., Markowitz, J., Wilder, P. T., Carrier, F. and Weber, D. J. (2004) Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J. Biol. Chem. 279, 34071-34077
45. Mueller, A., Schafer, B. W., Ferrari, S., Weibel, M., Makek, M., Hochli, M. and Heizmann, C. W. (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem. 280, 29186-29193
46. Scotto, C., Deloulme, J. C., Rousseau, D., Chambaz, E. and Baudier, J. (1998) Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell. Biol. 18, 4272-4281
47. Grigorian, M., Andresen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., Cohn, M., Ambartsumian, N., Christensen, A., Selivanova, G. and Lukanidin, E. (2001) Tumour suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 276, 22699-22708